These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
481 related articles for article (PubMed ID: 21039314)
1. Bioadhesive delivery systems for mucosal vaccine delivery. Baudner BC; O'Hagan DT J Drug Target; 2010 Dec; 18(10):752-70. PubMed ID: 21039314 [TBL] [Abstract][Full Text] [Related]
2. Recent advances in mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymeric carriers. Mishra N; Goyal AK; Tiwari S; Paliwal R; Paliwal SR; Vaidya B; Mangal S; Gupta M; Dube D; Mehta A; Vyas SP Expert Opin Ther Pat; 2010 May; 20(5):661-79. PubMed ID: 20345332 [TBL] [Abstract][Full Text] [Related]
3. Mucosal delivery of vaccine antigens and its advantages in pediatrics. De Magistris MT Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335 [TBL] [Abstract][Full Text] [Related]
4. Routes of immunization and antigen delivery systems for optimal mucosal immune responses in humans. Mestecky J; Michalek SM; Moldoveanu Z; Russell MW Behring Inst Mitt; 1997 Feb; (98):33-43. PubMed ID: 9382757 [TBL] [Abstract][Full Text] [Related]
5. Nasal vaccine innovation. Jabbal-Gill I J Drug Target; 2010 Dec; 18(10):771-86. PubMed ID: 21047271 [TBL] [Abstract][Full Text] [Related]
6. Immunity in response to particulate antigen-delivery systems. Storni T; Kündig TM; Senti G; Johansen P Adv Drug Deliv Rev; 2005 Jan; 57(3):333-55. PubMed ID: 15560945 [TBL] [Abstract][Full Text] [Related]
7. Mucosal delivery of vaccines in domestic animals. Gerdts V; Mutwiri GK; Tikoo SK; Babiuk LA Vet Res; 2006; 37(3):487-510. PubMed ID: 16611560 [TBL] [Abstract][Full Text] [Related]
8. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery. Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762 [TBL] [Abstract][Full Text] [Related]
17. Transcutaneous immunization with novel lipid-based adjuvants induces protection against gastric Helicobacter pylori infection. Hickey DK; Aldwell FE; Tan ZY; Bao S; Beagley KW Vaccine; 2009 Nov; 27(50):6983-90. PubMed ID: 19800441 [TBL] [Abstract][Full Text] [Related]
18. New insights in mucosal vaccine development. Pavot V; Rochereau N; Genin C; Verrier B; Paul S Vaccine; 2012 Jan; 30(2):142-54. PubMed ID: 22085556 [TBL] [Abstract][Full Text] [Related]
19. Biodegradable polymer microspheres as vaccine adjuvants and delivery systems. Gupta RK; Chang AC; Siber GR Dev Biol Stand; 1998; 92():63-78. PubMed ID: 9554260 [TBL] [Abstract][Full Text] [Related]
20. New generation of mucosal adjuvants for the induction of protective immunity. Yuki Y; Kiyono H Rev Med Virol; 2003; 13(5):293-310. PubMed ID: 12931340 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]